Tune in as PwC specialists discuss how emerging companies (private, pre-IPO) are navigating growth in the health industry.

Key topics include:

• The journey and milestones of emerging companies in the life sciences, biotech and medical technology fields, including capital raising, product development and IPO preparation
• Common pitfalls and best practices for managing diverse interests from investors and stakeholders
• Examples of how emerging companies are leveraging AI and other technologies to prioritize programs, design clinical trials and communicate value proposition

Speakers:
Holly Reeves, Health Industries - Emerging Company Solutions Market Leader, PwC US
Christian Jester, Technology, Media & Telecommunications - Emerging Company Solutions Market Leader, PwC US
Jenny Colapietro, Health Industries Vice Chair, PwC, US

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune in as PwC specialists discuss the 2024 outlook for healthcare and how the sector can grow and innovate amid economic challenges and uncertainty.

Key Topics include:

• Major forces impacting the sector: economic pressure, rising costs, labor shortage, and expensive drugs
• Ways to overcome compression and deliver value: industry-wide transformation, tech enabled business model reinvention, transactions and deals to drive transformation, and building trust

Speakers:
Laura Robinette, Health Industries Trust Solutions Leader, PwC, US
Thom Bales, Health Services Leader, PwC, US
Jenny Colapietro, Health Industries Vice Chair, PwC, US

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune in to hear PwC specialists discuss strategies to reinvent the pharma business model and drive growth in the pharmaceutical industry.

Key topics include:

• The headwinds for pharma are real and sustained
• Rethinking the innovation strategy
• Accelerate using AI and analytics
• Lower costs
• M&A as a catalyst for transformation
• Protecting the enterprise

Speakers:

Jenny Colapietro, Health Industries Vice Chair, PwC
Glenn Hunzinger, Pharmaceutical and Life Sciences Leader, PwC
Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader, PwC

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.